Forte Biosciences (FBRX) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$0.0.
- Forte Biosciences' EPS (Basic) rose 9939.99% to -$0.0 in Q1 2020 from the same period last year, while for Sep 2020 it was -$1.78, marking a year-over-year decrease of 508030.02%. This contributed to the annual value of -$30.13 for FY2019, which is 113447.32% down from last year.
- Per Forte Biosciences' latest filing, its EPS (Basic) stood at -$0.0 for Q1 2020, which was up 9939.99% from -$5.02 recorded in Q4 2019.
- In the past 5 years, Forte Biosciences' EPS (Basic) ranged from a high of -$0.0 in Q1 2020 and a low of -$5.02 during Q4 2019
- Moreover, its 5-year median value for EPS (Basic) was -$0.74 (2017), whereas its average is -$1.73.
- As far as peak fluctuations go, Forte Biosciences' EPS (Basic) crashed by 41366.72% in 2019, and later surged by 9939.99% in 2020.
- Quarter analysis of 5 years shows Forte Biosciences' EPS (Basic) stood at -$3.85 in 2016, then skyrocketed by 80.71% to -$0.74 in 2017, then tumbled by 31.73% to -$0.98 in 2018, then crashed by 413.67% to -$5.02 in 2019, then skyrocketed by 99.91% to -$0.0 in 2020.
- Its EPS (Basic) was -$0.0 in Q1 2020, compared to -$5.02 in Q4 2019 and -$0.01 in Q3 2019.